Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: A prospective, open, pilot study

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 11-12, 2004, Pages 1347-1352

  Domenech E ^a   Hinojosa, J ^b   Esteve Comas, M ^c   Gomollon F ^d   Herrera, J M ^e   Bastida, G ^f   Obrador, A ^g   Ruiz, R ^h   Saro, C ⁱ   Gassull, M A ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b Hospital Sagunto   (Spain)

^c HOSPITAL MÚTUA DE TERRASSA   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^h Hospital Universitario Reina Sofia Cordoba   (Argentina)

ⁱ HOSPITAL DE CABUEÑES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOMODULATING AGENT; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; STEROID;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; FEMALE; GRANULOCYTAPHERESIS; HUMAN; MALE; MULTICENTER STUDY; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GRANULOCYTES; HUMANS; LEUKAPHERESIS; MALE; PILOT PROJECTS; PREDNISOLONE; PROSPECTIVE STUDIES; REMISSION INDUCTION;

EID: 19944425563     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02288.x     Document Type: Article

References (27)

1. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35: 360-2.
2. Faubion WA, Jr, Loftus EV, Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-260.
3. Rutgeerts P. Review article: the limitations of corticosteroid therapy in Crohn's disease. Aliment Pharmacol Ther 2001; 15: 1515-25.
4. Present DH. How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis 2000; 6: 48-57.
5. Fraser AG, Orchard TR, Jewell DP. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 2002; 50: 485-9.
6. López-Sanromán A, Bermejo F, Carrera E, García-Plaza A. Efficacy and safety of thiopurine immunomodulators (azathioprine and mercaptopurine) in steroid-dependent ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 161-6.
7. Fraser AG. Methotrexate: first-line or second-line immunomodulator? Eur J Gastroenterol Hepatol 2003; 15: 225-31.
8. Colombel J-F, Loftus EV, Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology 2004; 126: 19-31.
9. Nagashima M, Yosino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi A. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study. Rheumatol Int 1998; 18: 113-8.
10. Kanekura T, Yoshii N, Yonezawa T, Kawabata H, Saruwatari H, Kanzaki T. Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Acad Dermatol 2003; 49: 329-332.
11. Neuwelt CM. The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Therap Apher Dial 2003; 7: 173-82.
12. Haas M, Mayr N, Zeitlhofer J, Goldammer A, Derfler K. Long-term treatment of myasthenia gravis with immunoadsorption. J Clin Apheresis 2002; 17: 84-87.
13. Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocytes and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001; 16: 1-9.
14. Naganuma M, Funakoshi S, Sakuraba A, et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 2004; 10: 251-7.
15. Hanai H, Watanabe F, Takeuchi K, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003; 1: 28-35.
16. Matsui T, Nishimura T, Matake H, Ohta T, Sakurai T, Yao T. Granulocyteapheresis for Crohn's disease: a report on seven refractory patients. Am J Gastroenterol 2003; 98: 511-2.
17. Kashiwagi N, Nakano M, Saniabadi AR, Adachi M, Yoshikawa T. Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis. Inflammation 2002; 26: 199-205.
18. Hiraishi K, Takeda Y, Shiobara N, et al. Studies on the mechasnisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Therap Apher Dial 2003; 7: 334-40.
19. Kashiwagi N, Sugimura K, Koiwai H, et al. Immunomodulatory effects of granulocytes and monocytes apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002; 47: 1334-41.
20. Rembacken BJ, Newbould HE, Richards SJ, et al. Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect. Ther Apher 1998; 2: 93-96.
21. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 24: 2-6.
22. Rachmilewitz D. Coated mesalazine (5-amino-salicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82-86.
23. 3 Gaffney PR, Doyle CT, Gaffney A, Hogan J, Hayes DP, Annis P. Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastroenterol 1995; 90: 220-3.
24. Evans RC, Wong VS, Morris AI, Rhodes JM. Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases. Aliment Pharmacol Ther 1997; 11: 1037-1040.
25. Panés J, Esteve M, Cabré E, et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology 2000; 119: 903-8.
26. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122: 512-30.
27. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology. Vienna 1998. Infl Bowel Dis 2000; 5: 8-15.